MoFo, Ropes, Mori Hamada guide Bain's $3.3 bln Mitsubishi Pharma buyout
BY Nimitt Dixit |
Morrison Foerster, Mori, Hamada & Matsumoto, and Ropes & Gray have advised U.S. investment fund Bain Capital on its planned 510-billion-yen ($3.3 billion) acquisition of Mitsubishi Tanabe Pharma Corporation from Mitsubishi Chemical Group Corporation.